We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » GAO Slams FDA for Momenta Ties Before Generic Lovenox Approval
GAO Slams FDA for Momenta Ties Before Generic Lovenox Approval
November 23, 2010
The Government Accountability Office (GAO) is criticizing the FDA for allowing a scientist from Momenta Pharmaceuticals to voluntarily assist the agency during its handling of the tainted heparin crisis in 2008, despite having an application for generic Lovenox still pending with the agency.